Telescope Innovations Corp.

220 - 887 Great Northern Way
Vancouver, BC
Canada V5T 4T5

Telescope Innovations Corp. is a technology company that leverages a unique combination of automation, analytics, and chemical process manufacturing expertise to develop next-generation platforms. We deploy them through partnerships to resolve bottlenecks and inefficiencies in chemical and pharmaceutical manufacturing.

Recent News

Telescope Innovations Is Granted a Canadian Patent on Chemical Synthesis Route
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been granted a Canadian patent, through its wholly-owned subsidiary, for a scalable manufacturing process to produce pharmaceutically-relevant indole compounds. Telescope developed this process in response to globally rising demands for pharmaceutical-grade therapeutics such as psilocybin and other indole-based precursors, analogs, and derivatives.The patented chemical...
2023-08-28 8:00 AM EDT
Telescope Announces Stock Option Grants
Vancouver, British Columbia--(Newsfile Corp. - August 3, 2023) - Telescope Innovations Corp. ("Telescope" or the "Company") (CSE: TELI), a chemical technology company, announces that it has granted a total of 800,000 incentive stock options (the "Options") to certain directors of the Company in accordance with the Company's incentive stock option plan.The Options are exercisable at a price of $0.27 until August 2, 2028, and vest in five tranches over a 12 month period with the first tranche vesting on August...
2023-08-03 8:31 PM EDT
Telescope Innovations Receives Accelerator Funding to Develop Carbon-Negative Production of Battery Materials
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $292,333 through Canada's Mining Innovation Commercialization Accelerator ("MICA") Network. Funds will support Telescope's development of carbon-negative production of lithium carbonate from continental brines. Telescope will deploy its unique automation and analytical technologies to accelerate the devel
2023-07-11 8:00 AM EDT
Telescope Innovations Delivers Continued Profitability in Fiscal Quarter 3, 2023
Vancouver, British Columbia--(Newsfile Corp. - June 29, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the third fiscal quarter ended May 31, 2023. Telescope is pleased to report solid growth in revenues since Q4, 2022 (Figure 1). The Company generated revenues of $1.01M and a net income of $67,847 in Q3, 2023, representing an increase of...
2023-06-29 8:00 AM EDT
Telescope Reports First Profitable Quarter: Fiscal Quarter 2, 2023
Vancouver, British Columbia--(Newsfile Corp. - April 25, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the second fiscal quarter ended February 28, 2023. Just over one year after securing facilities, assembling a team, and outfitting a research laboratory, the Company posted its third consecutive quarter of revenue and delivered its first profitable quarter (Figure 1).
2023-04-25 8:00 AM EDT
Telescope Reports First Fiscal Quarter 2023 Results
Vancouver, British Columbia--(Newsfile Corp. - February 8, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the first fiscal quarter ended November 30, 2022. The Company also announces its participation in investor events and technical conferences."We are pleased to report our second consecutive quarter of revenues. Telescope continues to build our customer base while implementing processes to...
2023-02-08 8:00 AM EST
Telescope Presents 2022 Fiscal Year Highlights and Investor Update
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, provides a financial and corporate update.KEY HIGHLIGHTSTelescope generated revenues of CAD $595,398 in its first full fiscal year of operation ending August 31, 2022 A new Master Services Agreement with Aqualung Carbon Capture Four investor outreach and client business development activities by the end of...
2023-01-23 8:00 AM EST
Telescope Announces Closing of $1.46 Million Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce that it has closed a non-brokered private placement (the "Offering").Upon closing of the Offering, the Company issued a total of 4,879,499 units ("Units") at a price of $0.30 per Unit for aggregate gross proceeds of $1,463,849. Each Unit consists of...
2022-11-10 5:05 PM EST
Telescope Announces Engagement with Natural Resources Canada to Develop Lithium Refinement Technology
Vancouver, British Columbia--(Newsfile Corp. - October 24, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces that it has been contracted by Natural Resources Canada ("NRCan") to help develop a critical lithium refinement technology. Over 16 months, Telescope will collaborate with NRCan to build an autonomous, self-driving experimental platform. The goal of this platform is to boost the efficiency of...
2022-10-24 8:00 AM EDT
Second Nobel Prize Won by Telescope Innovations Advisor
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced chemical technologies, announced today that K. Barry Sharpless, a member of Telescope's Scientific Advisory Board, and W.M. Keck Professor of Chemistry at Scripps Research, was awarded the 2022 Nobel Prize in Chemistry. Prof. Sharpless shares the award with Carolyn Bertozzi of Stanford and Morten Meldal of the University of Copenhagen, Denmark for the development of...
2022-10-06 11:00 AM EDT

« Back

Telescope Innovations Corp.

Recent News

Get News by Email

Stock Quote

RSS Feeds

Tell Us Your Story

Cookie Settings

Get News by Email

Stock Quote

RSS Feeds

Tell Us Your Story